Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Vaccination against hepatitis B in man].

P Maupas, A Goudeau, P Coursaget

    La Nouvelle Presse Medicale
    |January 1, 1977
    PubMed
    Summary

    This study details a new hepatitis B vaccine made from purified and inactivated HBsAg. The vaccine effectively protects against hepatitis B infection, offering a potential strategy for preventing liver cancer.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    [Human papillomavirus (HPV) vaccines].

    Virologie (Montrouge, France)·2021
    Same author

    [Early resistance to adefovir during treatment of a chronic hepatitis B].

    Virologie (Montrouge, France)·2021
    Same author

    [The genetic diversity of hepatitis C virus and its implications for pathogenesis and resistance to treatment].

    Virologie (Montrouge, France)·2021
    Same author

    Fatal outcome after reactivation of inherited chromosomally integrated HHV-6A (iciHHV-6A) transmitted through liver transplantation.

    American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons·2018
    Same author

    Detection of Bartonella in cat scratch disease using a single-step PCR assay kit.

    Journal of medical microbiology·2017
    Same author

    Impact on the medical decision-making process of multiplex PCR assay for respiratory pathogens.

    Epidemiology and infection·2017

    Area of Science:

    • Hepatitis B virus (HBV) research
    • Vaccine development and immunology
    • Viral oncology

    Context:

    • Hepatitis B virus (HBV) poses a significant global health risk, particularly in tropical regions where it is linked to primary liver cancer.
    • High-risk environments like haemodialysis units necessitate effective preventative measures against HBV transmission.

    Purpose:

    • To describe the preparation and purification of a novel vaccine against hepatitis B using HBsAg.
    • To evaluate the safety and efficacy of this HBsAg vaccine in preclinical (chimpanzee) and clinical settings.
    • To assess the vaccine's potential in preventing HBV infection and its oncogenic sequelae.

    Summary:

    • A vaccine was prepared from purified and formalin-inactivated Hepatitis B surface antigen (HBsAg), isolated via immunoadsorbent technique from donor blood.
    • Inocuity and efficacy were confirmed in chimpanzees, followed by vaccination trials in a high-risk haemodialysis unit.
    • Humoral and cellular immune responses against HBsAg were measured, alongside HBs antigenaemia, demonstrating vaccine-induced protection against hepatitis B.

    Impact:

    • Successful immunization against hepatitis B offers a crucial tool for preventing HBV infection.
    • This vaccine represents a potential breakthrough in preventing a viral infection linked to primary liver cancer, particularly in endemic areas.
    • The findings support the aetiological role of HBV in liver carcinogenesis and highlight the promise of viral immunization for cancer prevention.

    Related Experiment Videos